GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome

BACKGROUND: The objective of this in vivo study is to evaluate in five rat models the pharmacologic effects and toxicity of a commercial hydro-alcoholic extract, GlucoMedix®, derived from Stevia rebaudiana and the pentacyclic chemotype of Uncaria Tomentosa (Willd.) DC, for use as a treatment for met...

Descripción completa

Detalles Bibliográficos
Autores principales: Villegas Vílchez, León F., Ascencios, Julio Hidalgo, Dooley, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905912/
https://www.ncbi.nlm.nih.gov/pubmed/35260150
http://dx.doi.org/10.1186/s12906-022-03538-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905912/
https://www.ncbi.nlm.nih.gov/pubmed/35260150
http://dx.doi.org/10.1186/s12906-022-03538-9

Ejemplares similares